Search the Newsroom
Filter By
News Type
Showing 1 - 10 of 50 results
Children’s Hospital of Philadelphia Researchers Show How Patellar Instability Affects Knee Development in Growing Youth
Researchers at Children’s Hospital of Philadelphia (CHOP) demonstrated how trochlear anatomy evolves during pediatric development with and without recurrent patellofemoral instability (PFI), a condition where the kneecap repeatedly slips out of its groove, causing pain, swelling and difficulty with physical activity. The findings, recently reported in a landmark study in the American Journal of Sports Medicine, highlighted that PFI in growing children worsens trochlear dysplasia, which can result in further kneecap instability, while those without PFI experienced natural improvements.

Global Impact of CHOP Radiology: The 2023 Outreach in Ethiopia
n 2008, a partnership was established between the Department of Radiology at Children’s Hospital of Philadelphia (CHOP) and Tikur Anbessa Specialized Hospital (TASH)/Addis Ababa University (AAU), in Addis Ababa, Ethiopia, with the aim of supporting pediatric radiology education during radiology residency at TASH.
Radiology: Key Member of the HI Team
For the children with focal hyperinsulinism, the radiologist’s interpretation of a 18F-DOPA PET/CT scan guides the surgeon, leading to a cure in 97% of cases.

CHOP Radiology and Urology Collaborate on 3-D Printing Method to Build Pediatric Urology Models
The Children’s Hospital Additive Manufacturing for Pediatrics (CHAMP) 3D Lab at Children’s Hospital of Philadelphia (CHOP) is on the cutting-edge of three-dimensional (3-D) technology.
CHOP Experts Share Cutting-Edge Innovations at Arab Health Exhibition
Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s Hospital of Philadelphia (CHOP) will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2023 Exhibition and Congress, taking place this week in Dubai.
New Study Shows AML Ages Immune Cells, Leading to Poor Treatment Response
A new study has found that acute myeloid leukemia (AML) ages and exhausts immune cells, impairing their ability to fight off cancer.
First Approved CAR T-Cell Therapy Shows Continued Benefits Five Years Later
New data on show CAR T-cell therapy leads to durable remission and long-term survival in children and young adults with relapsed or refractory B-ALL.
CHOP Researchers Develop Allogeneic CART for Relapsed or Refractory T-ALL Using Base Editing
CHOP researchers have tested and developed an “off-the-shelf” chimeric antigen receptor T-cell (CART) using base editing.
Dr. Kassa Darge Presented Global Humanitarian Award from The American College of Radiology Foundation
Dr. Darge was recognized for his leadership in international medical outreach over his 30-year career.
CHOP Brings Together Experts to Discuss Precision Medicine in Pediatric Cancer Care
More than 250 experts gathered in Philadelphia and virtually to discuss the latest scientific advancements and breakthroughs in pediatric precision medicine oncology.